Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 2020
Specific targeting of ovarian tumor-associated macrophages by large, anionic nanoparticles
Tom Haber, Yvonne R Cornejo, Soraya Aramburo, et al.
Cancer Letters
|
December 29, 2014
Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells
Yujun Wang, Ernest Han, Quanhua Xing, et al.
Cancer Chemotherapy and Pharmacology
|
January 10, 2019
A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity
Mihaela C Cristea, Paul Frankel, Timothy Synold, et al.
Pleura and Peritoneum
|
March 23, 2026
Multicenter dose de-escalation phase I trial of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) nab-paclitaxel and cisplatin in combination with systemic nab-paclitaxel in recurrent ovarian cancer patients: trial in progress
Vinita Popat, Paul H Frankel, Nora H Ruel, et al.
Gynecologic Oncology
|
January 23, 2024
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancer
Mihaela C Cristea, Daphne Stewart, Timothy Synold, et al.
Antioxidants (Basel, Switzerland)
|
April 14, 2025
The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate
Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu, et al.
Antioxidants (Basel, Switzerland)
|
December 30, 2025
Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. <i>Antioxidants</i> 2025, <i>14</i>, 345
Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 4, 2014
Uterine neoplasms, version 1.2014
Wui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 15, 2015
Cervical Cancer, Version 2.2015
Wui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 15, 2013
Cervical cancer
Wui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 2020
Specific targeting of ovarian tumor-associated macrophages by large, anionic nanoparticles
Tom Haber, Yvonne R Cornejo, Soraya Aramburo, et al.
Cancer Letters
|
December 29, 2014
Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells
Yujun Wang, Ernest Han, Quanhua Xing, et al.
Cancer Chemotherapy and Pharmacology
|
January 10, 2019
A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity
Mihaela C Cristea, Paul Frankel, Timothy Synold, et al.
Pleura and Peritoneum
|
March 23, 2026
Multicenter dose de-escalation phase I trial of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) nab-paclitaxel and cisplatin in combination with systemic nab-paclitaxel in recurrent ovarian cancer patients: trial in progress
Vinita Popat, Paul H Frankel, Nora H Ruel, et al.
Gynecologic Oncology
|
January 23, 2024
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancer
Mihaela C Cristea, Daphne Stewart, Timothy Synold, et al.
Antioxidants (Basel, Switzerland)
|
April 14, 2025
The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate
Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu, et al.
Antioxidants (Basel, Switzerland)
|
December 30, 2025
Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. <i>Antioxidants</i> 2025, <i>14</i>, 345
Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 4, 2014
Uterine neoplasms, version 1.2014
Wui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 15, 2015
Cervical Cancer, Version 2.2015
Wui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 15, 2013
Cervical cancer
Wui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.
Page
of 4